asuragen.com
asuragen.com
Get leads like Asuragen — and thousands more
Build targeted lists by tech stack, traffic, and more
Asuragen: The Stealth Giant in Fragile X
A $24M biotech quietly dominating a critical genetic diagnostic niche
While most biotech startups chase flashy headlines, Asuragen operates in the shadows of clinical precision. With $80M in funding and a laser focus on Fragile X syndrome, they've built a $24M revenue engine that most investors have completely overlooked.
"In genetic diagnostics, you don't need millions of visitors—you need the right 7,631."
The Fragile X Monopoly
Asuragen isn't trying to be everything to everyone. Their search data reveals a stunning concentration: 'fragile x' alone drives 4,810 monthly searches, dwarfing their brand terms. They've essentially cornered a high-stakes diagnostic niche where parents and clinicians have zero tolerance for error. This isn't a numbers game—it's a precision play where being the default choice for a rare condition is worth more than broad market presence.
The $80M Question
Here's the paradox: $80M in funding for a company generating $24M with just 166 employees suggests either extreme efficiency or a patient capital strategy. Unlike biotech rockets that burn bright and fast, Asuragen's 49% direct traffic indicates they're not chasing growth—they're serving a captive audience. The 'asuragen, a bio-techne brand' keyword (80 monthly searches) hints at their strategic positioning under a larger umbrella, likely providing stability over scale.
- Deep CLIA lab integration (CLIA ID: 45d1069375) creates a moat that pure software competitors can't cross
- Executive team focused on operations and manufacturing—telling signs of a company scaling infrastructure, not marketing
- The 'premutation fragile X' search volume (290 monthly) reveals a specific patient community they serve intimately
The traffic geography is telling: 66.7% from undefined sources, likely internal systems, patient portals, and clinical networks. This isn't a consumer-facing website—it's a B2B2C infrastructure play where the real transactions happen through hospital systems and specialist networks. The 7,631 monthly visits represent high-intent clinicians and desperate families, not casual browsers.
The Silent Giant Strategy
Asuragen proves you don't need to be a unicorn to be indispensable
How much traffic does Asuragen get?
Traffic & Engagement
Traffic Sources
Where is Asuragen's audience located?
What keywords does Asuragen rank for?
5 keywordsWhat is Asuragen's revenue?
Who works at Asuragen?
Loading leads...
What do customers think of Asuragen?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Asuragen
What is Asuragen's Revenue?
How fast is Asuragen growing?
Who are Asuragen's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
Export asuragen.com Data
Download the complete tech stack, analytics, leads, and company data for asuragen.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About asuragen.com
Company Overview
Traffic & Audience
asuragen.com receives approximately 7.6K monthly visitors and ranks #2,797,349 globally. The website has a bounce rate of 48% with visitors viewing an average of 1.7 pages per visit. Users spend an average of 0:17 on the site.
The majority of asuragen.com's traffic comes from undefined, undefined, .
Frequently Asked Questions
What is asuragen.com?
How popular is asuragen.com?
Related Searches
This page provides publicly available information about asuragen.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit asuragen.com directly at https://asuragen.com.